α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
Compounds having a formula: or a pharmaceutically acceptable salt or prodrug thereof, are provided, and are useful for the treatment of metabolic disorders.
1. A compound having the formula
and all pharmaceutically acceptable salts and prodrugs thereof, wherein
X is a member selected from the group consisting of O, and NR, wherein R is H,
Y is a member selected from the group consisting of CH 2 OR c and CO 2 R c , wherein R c is a member selected from the group consisting of H, (C 1 -C 8 )alkyl, and (C 1 -C 8 )alkylene-Z, wherein Z is selected from the group consisting of COR d , COOR d , NR d R e , NR d CONR c R f , NR d COR c , NR d COOR c and CONR d R e wherein R d , R e and R f are each independently selected from the group consisting of H, (C 1 -C 8 )alkyl and phenyl;
each R 1 and R 3 is a member independently selected from the group consisting of halogen, (C 1 -C 8 )alkyl, (C 1 -C 8 )alkoxy, (C 1 -C 8 )haloalkyl, O(C 1 -C 8 )haloalkyl, and nitro;
R 2 is a member selected from the group consisting of H and CH 3 ;
Q is C
the subscript m is an integer of from 0 to 2; and
the subscript p is an integer of from 0 to 1.
2. A compound of claim 1 , wherein Y is CO 2 R c .
3. A compound of claim 1 , wherein each R 1 is selected from the group consisting of halogen, nitro, (C 1 -C 8 ) alkyl and (C 1 -C 8 ) alkoxy; and each R 3 is selected from the group consisting of halogen, nitro, (C 1 -C 8 ) alkyl and (C 1 -C 8 ) alkoxy.
4. A compound of claim 3 , wherein X is O and Y is CO 2 R c .
5. A compound of claim 3 , wherein X is O and Y is CH 2 OR c .
6. A compound of claim 3 , wherein X is NH and Y is CO 2 R c .
7. A compound of claim 3 , wherein X is NH and Y is CH 2 OR c .
8. A composition comprising a pharmaceutically acceptable excipient and a compound having a formula:
and all pharmaceutically acceptable salts and prodrugs thereof, wherein
X is a member selected from the group consisting of O, and NR, wherein R is H,
Y is a member selected from the group consisting of CH 2 OR c and CO 2 R c , wherein R c is a member selected from the group consisting of H, (C 1 -C 8 )alkyl, and (C 1 -C 8 )alkylene-Z, wherein Z is selected from the group consisting of COR d , COOR d , NR d R e , NR d CONR e R f , NR d COR e , NR d COOR e and CONR d R e wherein R d , R e and R f are each independently selected from the group consisting of H, (C 1 -C 8 )alkyl and phenyl;
each R 1 and R 3 is a member independently selected from the group consisting of halogen, (C 1 -C 8 )alkyl, (C 1 -C 8 )alkoxy, (C 1 -C 8 )haloalkyl, O(C 1 -C 8 )haloalkyl, and nitro,
R 2 is a member selected from the group consisting of H and CH 3 ;
Q is C
the subscript m is an integer of from 0 to 2; and
the subscript p is an integer of from 0 to 1.
9. A compound selected from the group consisting of:
(4-Trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid;
(2-Trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid;
(4-Trifluoromethyl-phenoxy)-(4-trifluoromethyl-phenyl)-acetic acid;
(3,5-Bis-trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid;
(2-Chloro-4-trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid;
(3-Trifluoromethyl-phenoxy)-(4-trifluoromethyl-phenyl)-acetic acid;
(2-Trifluoromethyl-phenoxy)-(4-trifluoromethyl-phenyl)-acetic acid;
(2-Chloro-4-trifluoromethyl-phenoxy)-(4-trifluoromethyl-phenyl)-acetic acid;
(2-Fluoro-5-trifluoromethyl-phenoxy)-(4-trifluoromethyl-phenyl)-acetic acid;
(3-Fluoro-5-trifluoromethyl-phenyl)-(5-methoxy-2-trifluoromethyl-phenoxy)-acetic acid;
(2,4-Bis-trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid ethyl ester;
(3-Trifluoromethyl-phenyl)-(2-trifluoromethyl-phenylamino)-acetic acid;
(3-Trifluoromethyl-phenyl)-(3-trifluoromethyl-phenylamino)-acetic acid;
(3,5-Bis-trifluoromethyl-phenylamino)-(3-trifluoromethyl-phenyl)-acetic acid;
(3-Trifluoromethyl-phenyl)-(4-trifluoromethyl-phenylamino)-acetic acid;
(4-Isopropyl-2-trifluoromethyl-phenylamino)-(3-trifluoromethyl-phenyl)-acetic acid;
(4-Trifluoromethyl-phenyl)-(2-trifluoromethyl-phenylamino)-acetic acid;
2-(4-Trifluoromethyl-phenoxy)-2-(3-trifluoromethyl-phenyl)-propionic acid;
2-(4-Trifluoromethyl-phenoxy)-2-(4-trifluoromethyl-phenyl)-propionic acid;
2-(2-Trifluoromethyl-phenoxy)-2-(3-trifluoromethyl-phenyl)-propionic acid;
2-(4-trifluoromethyl-phenoxy)-2-(3-trifluoromethyl-phenyl)-ethanol;
(4-trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid 2-acetylamino-ethyl ester;
(4-trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid sodium salt;
(+)-(4-trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid; and
(−)-(4-trifluoromethyl-phenoxy)-(3-trifluoromethyl-phenyl)-acetic acid.
10. A compound selected from the group consisting of: